Technical Analysis for ABIO - ARCA biopharma, Inc.
Trend Table & Recent Alerts
|Weak or Absent||Down||Down||Flat|
|See historical ABIO trend table...|
|Date||Alert Name||Type||% Chg|
|Feb 23||Bollinger Band Squeeze||Range Contraction||0.00%|
|Feb 22||NR7||Range Contraction||-1.92%|
|Feb 22||Narrow Range Bar||Range Contraction||-1.92%|
|Feb 22||Bollinger Band Squeeze||Range Contraction||-1.92%|
|Feb 22||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||-1.92%|
|Feb 21||Narrow Range Bar||Range Contraction||0.00%|
|Feb 21||Bollinger Band Squeeze||Range Contraction||0.00%|
|Feb 17||Bullish Engulfing||Bullish||0.00%|
|Feb 17||Bollinger Band Squeeze||Range Contraction||0.00%|
|Feb 16||Fell Below 50 DMA||Bearish||2.00%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
- Earnings date: 2017-03-15
- Sector: Health Care
- Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
Is ABIO a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ABIO news...
|52 Week High||4.35|
|52 Week Low||2.15|
|200-Day Moving Average||2.79|
|50-Day Moving Average||2.62|
|20-Day Moving Average||2.56|
|10-Day Moving Average||2.56|
|Average True Range||0.12|
|Chandelier Exit (Long, 3 ATRs)||2.44|
|Chandelier Exit (Short, 3 ATRs)||2.81|
|Upper Bollinger Band||2.64|
|Lower Bollinger Band||2.48|
|Percent B (%b)||0.44|